Your browser doesn't support javascript.
loading
NRF2 activation induced by PML-RARα promotes microRNA 125b-1 expression and confers resistance to chemotherapy in acute promyelocytic leukemia.
Yu, Xibao; Mansouri, Ardalan; Liu, Zhuandi; Gao, Rili; Li, Kehan; Chen, Cunte; Huang, Youxue; Chen, Zheng; Chen, Shaohua; Lu, Yuhong; Li, Yangqiu; Zeng, Chengwu; Zeng, Yixin.
Afiliação
  • Yu X; Department of Experimental Research, Sun Yat-Sen University Cancer Center, State Key Laboratory Oncology in South China, Guangzhou, China.
  • Mansouri A; Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.
  • Liu Z; Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.
  • Gao R; Department of Anatomy and Molecular Embryology, Institute of Anatomy, Ruhr-University Bochum, Bochum, Germany.
  • Li K; Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.
  • Chen C; Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.
  • Huang Y; Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.
  • Chen Z; Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.
  • Chen S; Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.
  • Lu Y; Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.
  • Li Y; Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.
  • Zeng C; Department of Hematology, First Affiliated Hospital, Jinan University, Guangzhou, China.
  • Zeng Y; Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.
Clin Transl Med ; 11(5): e418, 2021 05.
Article em En | MEDLINE | ID: mdl-34047481
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Promielocítica Aguda / Proteínas de Fusão Oncogênica / Resistencia a Medicamentos Antineoplásicos / MicroRNAs / Fator 2 Relacionado a NF-E2 / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Promielocítica Aguda / Proteínas de Fusão Oncogênica / Resistencia a Medicamentos Antineoplásicos / MicroRNAs / Fator 2 Relacionado a NF-E2 / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article